FDA approves rifapentine for the treatment of pulmonary tuberculosis.... Food and Drug Administration.
Roehr
B
B
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000995:Antitubercular Agents; D012293:Rifampin